WallStSmart

DHI Group Inc (DHX)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 103% more annual revenue ($258.90M vs $127.83M). DHX leads profitability with a -10.6% profit margin vs -15.5%. DHX earns a higher WallStSmart Score of 52/100 (C-).

DHX

Buy

52

out of 100

Grade: C-

Growth: 4.7Profit: 4.0Value: 6.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DHXUndervalued (+59.9%)

Margin of Safety

+59.9%

Fair Value

$5.98

Current Price

$2.39

$3.59 discount

UndervaluedFair: $5.98Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DHX2 strengths · Avg: 9.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

EPS GrowthGrowth
36.8%8/10

Earnings expanding 36.8% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

DHX4 concerns · Avg: 2.8/10
PEG RatioValuation
1.564/10

Expensive relative to growth rate

Market CapQuality
$123.22M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-12.9%2/10

ROE of -12.9% — below average capital efficiency

Revenue GrowthGrowth
-10.2%2/10

Revenue declined 10.2%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : DHX

The strongest argument for DHX centers on Price/Book, EPS Growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : DHX

The primary concerns for DHX are PEG Ratio, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

DHX profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DHX scores higher overall (52/100 vs 41/100). ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DHI Group Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

DHI Group, Inc. provides data, knowledge and job connections through specialized services for technology professionals in the United States, the United Kingdom, the rest of Europe, the Middle East, Africa, Asia Pacific and internationally. The company is headquartered in Centennial, Colorado.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?